Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $153.4350 (0.39%) ($153.4350 - $153.4350) on Mon. Nov. 8, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.95% (three month average) | RSI | 82 | Latest Price | $153.4350(0.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND advances 8.2% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(59%) IWM(57%) IWC(54%) IWN(53%) | Factors Impacting LGND price | LGND will decline at least -1.475% in a week (0% probabilities). VIXM(-28%) VXX(-17%) UUP(-17%) UNG(-5%) TBT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.475% (StdDev 2.95%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $156.46(-1.93%) | 10 Day Moving Average | $150.96(1.64%) | 20 Day Moving Average | $141.63(8.34%) | To recent high | -4.1% | To recent low | 49.8% | Market Cap | $2.466b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |